159 related articles for article (PubMed ID: 27483975)
1. COSTS OF DEPRESSION FROM CLAIMS DATA FOR MEDICARE RECIPIENTS IN A POPULATION-BASED SAMPLE.
Alexandre PK; Hwang S; Roth KB; Gallo JJ; Eaton WW
J Health Hum Serv Adm; 2016; 39(1):72-94. PubMed ID: 27483975
[TBL] [Abstract][Full Text] [Related]
2. Costs of substance use disorders from claims data for Medicare recipients from a population-based sample.
Fairman BJ; Hwang S; Alexandre PK; Gallo JJ; Eaton WW
J Subst Abuse Treat; 2017 Jun; 77():174-177. PubMed ID: 28242082
[TBL] [Abstract][Full Text] [Related]
3. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
4. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
[TBL] [Abstract][Full Text] [Related]
5. Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.
Ivanova JI; Birnbaum HG; Chen L; Duhig AM; Dayoub EJ; Kantor ES; Schiller MB; Phillips GA
Am J Manag Care; 2011 Aug; 17(8):e314-23. PubMed ID: 21851139
[TBL] [Abstract][Full Text] [Related]
6. Healthcare costs associated with depression in medically Ill fee-for-service medicare participants.
Unützer J; Schoenbaum M; Katon WJ; Fan MY; Pincus HA; Hogan D; Taylor J
J Am Geriatr Soc; 2009 Mar; 57(3):506-10. PubMed ID: 19175438
[TBL] [Abstract][Full Text] [Related]
7. Incremental Health Care Burden of Treatment-Resistant Depression Among Commercial, Medicaid, and Medicare Payers.
Shrestha A; Roach M; Joshi K; Sheehan JJ; Goutam P; Everson K; Heerlein K; Jena AB
Psychiatr Serv; 2020 Jun; 71(6):593-601. PubMed ID: 32237982
[TBL] [Abstract][Full Text] [Related]
8. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
Birnbaum HG; Kessler RC; Kelley D; Ben-Hamadi R; Joish VN; Greenberg PE
Depress Anxiety; 2010; 27(1):78-89. PubMed ID: 19569060
[TBL] [Abstract][Full Text] [Related]
9. Relationship of a Claims-Based Frailty Index to Annualized Medicare Costs: A Cohort Study.
Johnston KJ; Wen H; Joynt Maddox KE
Ann Intern Med; 2020 Apr; 172(8):533-540. PubMed ID: 32252070
[TBL] [Abstract][Full Text] [Related]
10. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of adults with major depressive disorder in the United States (2005 and 2010).
Greenberg PE; Fournier AA; Sisitsky T; Pike CT; Kessler RC
J Clin Psychiatry; 2015 Feb; 76(2):155-62. PubMed ID: 25742202
[TBL] [Abstract][Full Text] [Related]
12. An Evaluation of the Clinical and Economic Burden Among Older Adult Medicare-Covered Beneficiaries With Treatment-Resistant Depression.
Benson C; Szukis H; Sheehan JJ; Alphs L; Yuce H
Am J Geriatr Psychiatry; 2020 Mar; 28(3):350-362. PubMed ID: 31735488
[TBL] [Abstract][Full Text] [Related]
13. Determinants of direct cost differences among US employees with major depressive disorders using antidepressants.
Birnbaum HG; Ben-Hamadi R; Greenberg PE; Hsieh M; Tang J; Reygrobellet C
Pharmacoeconomics; 2009; 27(6):507-17. PubMed ID: 19640013
[TBL] [Abstract][Full Text] [Related]
14. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
[TBL] [Abstract][Full Text] [Related]
15. Incident hypertension associated with depression in the Baltimore Epidemiologic Catchment area follow-up study.
Meyer CM; Armenian HK; Eaton WW; Ford DE
J Affect Disord; 2004 Dec; 83(2-3):127-33. PubMed ID: 15555705
[TBL] [Abstract][Full Text] [Related]
16. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
McCombs JS; Ahn J; Tencer T; Shi L
J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
[TBL] [Abstract][Full Text] [Related]
17. Impact of depressive symptoms on direct medical cost among medicare recipients with knee osteoarthritis.
Yang HY; Song ZS; Collins JE; Losina E
Osteoarthritis Cartilage; 2024 Jul; 32(7):922-930. PubMed ID: 38710438
[TBL] [Abstract][Full Text] [Related]
18. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
19. Medicare patient experience with vagus nerve stimulation for treatment-resistant depression.
Feldman RL; Dunner DL; Muller JS; Stone DA
J Med Econ; 2013; 16(1):62-74. PubMed ID: 22954061
[TBL] [Abstract][Full Text] [Related]
20. Patients with obsessive-compulsive disorder vs depression have comparable health care costs: a retrospective claims analysis of Florida Medicaid enrollees.
Hankin CS; Koran L; Sheehan DV; Hollander E; Culpepper L; Black DW; Knispel J; Dunn J; Dougherty DD; Bronstone A; Wang Z
Ann Clin Psychiatry; 2011 Nov; 23(4):285-96. PubMed ID: 22073386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
